ghk-cu cancer risk angiogenesis Novel mono-, bi-, tri- and tetra-nuclear copper complexes that inhibit tumor growth through apoptosis and anti-angiogenesis Type:5000 mcg/ml - 30mL vial BPC-157/TB-500 10mg/10mg - Certified bunde
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22